Kim Y - Search Results

1

The synthetic chemoattractant peptide, Trp-Lys-Tyr-Met-Val-D-Met, enhances monocyte survival via PKC-dependent Akt activation.

Bae YS, Kim Y, Park JC, Suh PG, Ryu SH. Bae YS, et al. Among authors: kim y. J Leukoc Biol. 2002 Feb;71(2):329-38. J Leukoc Biol. 2002. PMID: 11818455

2

Differential activation of formyl peptide receptor signaling by peptide ligands.

Bae YS, Song JY, Kim Y, He R, Ye RD, Kwak JY, Suh PG, Ryu SH. Bae YS, et al. Among authors: kim y. Mol Pharmacol. 2003 Oct;64(4):841-7. doi: 10.1124/mol.64.4.841. Mol Pharmacol. 2003. PMID: 14500740

3

Identification of a compound that directly stimulates phospholipase C activity.

Bae YS, Lee TG, Park JC, Hur JH, Kim Y, Heo K, Kwak JY, Suh PG, Ryu SH. Bae YS, et al. Among authors: kim y. Mol Pharmacol. 2003 May;63(5):1043-50. doi: 10.1124/mol.63.5.1043. Mol Pharmacol. 2003. PMID: 12695532

4

Novel chemoattractant peptides for human leukocytes.

Bae YS, Park EY, Kim Y, He R, Ye RD, Kwak JY, Suh PG, Ryu SH. Bae YS, et al. Among authors: kim y. Biochem Pharmacol. 2003 Nov 1;66(9):1841-51. doi: 10.1016/s0006-2952(03)00552-5. Biochem Pharmacol. 2003. PMID: 14563494

5

Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1.

Kim Y, Lee BD, Kim O, Bae YS, Lee T, Suh PG, Ryu SH. Kim Y, et al. Among authors: kim o. J Immunol. 2006 Mar 1;176(5):2969-75. doi: 10.4049/jimmunol.176.5.2969. J Immunol. 2006. PMID: 16493055

6

Collapsin response mediator protein-2 inhibits neuronal phospholipase D(2) activity by direct interaction.

Lee S, Kim JH, Lee CS, Kim JH, Kim Y, Heo K, Ihara Y, Goshima Y, Suh PG, Ryu SH. Lee S, et al. Among authors: kim y, kim jh. J Biol Chem. 2002 Feb 22;277(8):6542-9. doi: 10.1074/jbc.M108047200. Epub 2001 Dec 10. J Biol Chem. 2002. PMID: 11741937 Free article.

7

Ligand profiling and identification technology for searching bioactive ligands.

Baek MC, Kim SJ, Yea K, Kim Y, Lee BD, Kim J, Lee HJ, Kang MH, Choi SK, Kim JI, Lee TG, Suh PG, Ryu SH. Baek MC, et al. Among authors: kim ji, kim sj, kim j, kim y. Proteomics. 2006 Mar;6(6):1741-9. doi: 10.1002/pmic.200500511. Proteomics. 2006. PMID: 16526000

8

Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis.

Lee YJ, Kim IS, Park SA, Kim Y, Lee JE, Noh DY, Kim KT, Ryu SH, Suh PG. Lee YJ, et al. Among authors: kim kt, kim is, kim y. Mol Ther. 2013 May;21(5):1004-13. doi: 10.1038/mt.2013.30. Epub 2013 Mar 19. Mol Ther. 2013. PMID: 23511245 Free PMC article.

9

Efficacy of newly discovered DNA aptamers targeting AXL in a lung cancer cell with acquired resistance to Erlotinib.

Hwang JA, Hur JY, Kim Y, Im JH, Jin SH, Ryu SH, Choi CM. Hwang JA, et al. Among authors: kim y. Transl Cancer Res. 2021 Feb;10(2):1025-1033. doi: 10.21037/tcr-20-2447. Transl Cancer Res. 2021. PMID: 35116429 Free PMC article.

10

Mechanistic understanding of insulin receptor modulation: Implications for the development of anti-diabetic drugs.

Yunn NO, Kim J, Kim Y, Leibiger I, Berggren PO, Ryu SH. Yunn NO, et al. Among authors: kim j, kim y. Pharmacol Ther. 2018 May;185:86-98. doi: 10.1016/j.pharmthera.2017.12.005. Epub 2017 Dec 18. Pharmacol Ther. 2018. PMID: 29262294 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86,163 results

Search Page

Filters